Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market

INDUSTRY
Healthcare

RELEASE DATE
04-Feb-2014
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
MA14-01-00-00-00
SKU
LS00099-NA-MR_16940
Yes
SHARE

Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market
Published on: 04-Feb-2014 | SKU: LS00099-NA-MR_16940

Need more details?

$3,950.00

$2,962.50 save 25 %

DownloadLink
Need more details?

This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinson’s Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for Parkinson’s Disease therapeutics. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.

Executive Summary

Recent Market Developments

Companies to Watch

Key Trends in Parkinson’s Disease Therapeutics

Methodology and Scope

Introduction

Global Prevalence of Parkinson’s Disease by Country

Global Incidence of Parkinson’s Disease by Country

Market Overview—Segmentation by Types of Therapeutics

Market Overview—Segmentation Illustrated

Market Overview—Segmentation Illustrated (continued)

Overview of Market Opportunities

Competitive Landscape—Marketed Products and Products in Development

Marketed Product Synopsis—Parkinson’s Disease Therapeutics

Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)

Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)

Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)

Pipeline Synopsis—Parkinson’s Disease Therapeutics

Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued

Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued

Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued

Parkinson’s Disease Therapeutics Market—Competitive Landscape: Major Ongoing Trials

Competitive Landscape—Projected Launch Timeline for Key Pipeline Drugs

Competitive Landscape—Company Assets by Drug Pipeline Class

Key Marketed Products Dashboard: Stalevo (Carbidopa-Levodopa-Entacapone)—Orion Corporation

Key Marketed Products Dashboard: Sinemet (carbidopa-levodopa)—Merck & Co

Key Marketed Products Dashboard: Azilect (Rasagiline) By TEVA Pharmaceuticals

Key Marketed Products Dashboard: Zelapar (Selagiline) By Valeant Pharmaceuticals

Key Marketed Products Dashboard: Mirapex (Pramipexole) By Boehringer Ingelheim

Key Marketed Products Dashboard: Neupro (Rotigotine) By UCB Inc. and Schwarz Pharma

Key Marketed Products Dashboard: Requip (Ropinirole) By Glaxo SmithKline

Key Phase 3 Products Dashboard:Nouriast® (Istradefylline) By Kyowa Hakko Kirin

Key Phase 2 Products Dashboard:Ampyra® (dalfampridine) By Acorda Therapeutics

Key Phase 3 Products Dashboard:Duodopa® (sinemet) By AbbVie Pharmaceutical

Conclusion

Conclusions (Continued)

Legal Disclaimer

Decision Support Database—Global Population with Parkinson’s Disease

Decision Support Database—Global Population with Parkinson’s Disease (continued)

Who is Frost & Sullivan

What Makes Us Unique

TEAM Methodology

Our Global Footprint 40+ Offices


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.